CLINICAL_TRIALS
ClinicalTrials.gov record update
Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06728852
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:03.964908+00:00
- Published At
- 2024-12-11T00:00:00+00:00
- Record Updated At
- 2024-12-11
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Advanced Non-small Cell Lung Cancer (NSCLC)", "Recurrent or Metastatic Lung Cancer", "Third-line and Beyond Therapy", "Angiogenesis Inhibition in Oncology"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-12-11"- protocolSection.identificationModule.nctId
"NCT06728852"- protocolSection.identificationModule.officialTitle
"Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.